PFE - FDA Allows Importing Unapproved But Essential Syphilis Treatment Amid Shortage Of Pfizer's Antibiotic | Benzinga
The FDA is working with a French drugmaker, Laboratoires Delbert, to temporarily allow the import of syphilis treatment amid an ongoing shortage.
In a letter on Wednesday, Delbert said that it's working with the FDA to temporarily import 3.5 million units of Extencilline, which is not approved in the U.S.
It's similar to Bicillin, a long-acting injectable form of the antibiotic penicillin made by Pfizer Inc (NYSE:PFE) that has been in short supply since the middle of last year.
The shortage is estimated to last through June, according ...